Dymium is a medical device startup. Our mission is to establish the new standard method for the extraction of kidney stones.
The current therapy options are based on the fragmentation of the stones. In this process, all resulting fragments must be located and extracted individually. Fragments left behind can lead to renewed stone growth, infections and colic. It is assumed that approximately 50% of the patients have to be treated again due to these residues.
We have developed an innovative method for minimally invasive removal of kidney stone fragments. We rely on magnetic forces to enable residue-free and smooth removal of the fragments.
Location: Germany, Bavaria, Garching bei München
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | Medical In... | mi-incubat... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 27.07.2022 | Minimally invasive removal of kidney stones: Dymium wins Mun... | Dymium develops a minimally invasive treatment method for the remnant-free removal of kidney stones ... | bio-m.org/... |
| 21.07.2022 | Munich scores at the Science4Life Business Plan Competition ... | Fusix Biotech, Dymium and Opsyon Therapeutics were persuasive in this year's business plan phase of ... | bio-m.org/... |
| 23.09.2021 | Dymium from Munich wins the BioRegions 2021 Innovation Award | At the start of the German Biotechnology Days 2021 in Stuttgart, the winners of this year's BioRegio... | bio-m.org/... |